Divi's Laboratories Limited (DIVISLAB) — Announcement | 1 August 2026(2 announcements)
Divi's Laboratories announced that the audio recording of its Q1 FY27 earnings conference call held on August 1, 2026, is now available on its investor relations website, providing shareholders access to management commentary on performance and outlook.
Divi's Laboratories announced its August 1, 2026 board meeting outcomes, approving unaudited standalone and consolidated financial results for Q1 FY2026 ending June 30, 2026, along with senior management appointments. The consolidated statement shows total income of ₹3,144 crores, up from ₹2,529 crores YoY, with profit before tax at ₹1,180 crores versus ₹733 crores previously, and profit after tax at ₹902 crores compared to ₹545 crores. Standalone figures report total income of ₹3,037 crores and PAT of ₹891 crores. The press release highlights 26% YoY growth in consolidated revenue and 66% YoY growth in PAT, reflecting strong operational performance.
About Divi's Laboratories Limited (DIVISLAB)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when DIVISLAB files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track DIVISLAB — Free💡 Ask AI about this filing
📊 More DIVISLAB filings
- Announcement — 31 July 2026 Divi's Laboratories announced the retirement of two senior executives, Vice President of Procurement...
- Announcement — 24 July 2026 Divi's Laboratories announced its Q1 FY27 earnings conference call on August 1, 2026, at 14:00 IST f...
- share transfer — 7 July 2026 Divi's Laboratories submitted a SEBI-mandated certificate from its share transfer agent KFin Technol...
- encumbrance — 6 July 2026 No summary available
- 🟡 Board Meeting — 11 June 2026 Divi's Laboratories announced a ₹30 per share dividend for FY2025-26, payable after August 14, 2026,...
🔥 Also filed on 1 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when DIVISLAB files new disclosures
Track DIVISLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track DIVISLAB — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research